Weiping Wang , Jiaqi Fan , Fengxiao Li , Shuo Gan , Jiaming Zhang , Yanfang Wang , Yingchao Li , Wenchao Li , Zhonggui He , Huaiwei Ding , Yongbing Sun , Tianhong Zhang , Qikun Jiang
{"title":"“设计、合成和评价氨基甲酸酯桥接氨基酸环虫苷前药,提高抗肿瘤活性、水溶性和II期代谢稳定性”的更正[欧洲]。J. Med. Chem. 276 (2024) 116646]","authors":"Weiping Wang , Jiaqi Fan , Fengxiao Li , Shuo Gan , Jiaming Zhang , Yanfang Wang , Yingchao Li , Wenchao Li , Zhonggui He , Huaiwei Ding , Yongbing Sun , Tianhong Zhang , Qikun Jiang","doi":"10.1016/j.ejmech.2025.117594","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"291 ","pages":"Article 117594"},"PeriodicalIF":6.0000,"publicationDate":"2025-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Design, synthesis and evaluation of carbamate-bridged amino acid prodrugs of cycloicaritin with improved antitumor activity, aqueous solubility and phase II metabolic stability” [Eur. J. Med. Chem. 276 (2024) 116646]\",\"authors\":\"Weiping Wang , Jiaqi Fan , Fengxiao Li , Shuo Gan , Jiaming Zhang , Yanfang Wang , Yingchao Li , Wenchao Li , Zhonggui He , Huaiwei Ding , Yongbing Sun , Tianhong Zhang , Qikun Jiang\",\"doi\":\"10.1016/j.ejmech.2025.117594\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":314,\"journal\":{\"name\":\"European Journal of Medicinal Chemistry\",\"volume\":\"291 \",\"pages\":\"Article 117594\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-04-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0223523425003599\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425003599","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Corrigendum to “Design, synthesis and evaluation of carbamate-bridged amino acid prodrugs of cycloicaritin with improved antitumor activity, aqueous solubility and phase II metabolic stability” [Eur. J. Med. Chem. 276 (2024) 116646]
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.